GlassScriptPhysician profile
Stephanie Elysse Farber
NPI 1265844617
$5,071.34
in general payments reported to CMS, 2019-2025
13 companies · $468 in 2025
The $468 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $175 · 2021: $797 · 2022: $1,139 · 2023: $1,216 · 2024: $1,278 · 2025: $468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,961.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,961.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,672.96 | 2023-2025 | Alloderm, Natrelle Saline-Filled Breast Implants, Botox |
| Allergan, INC. | $1,459.15 | 2020-2022 | |
| Coloplast Corp | $261.94 | 2021-2022 | |
| Mentor Worldwide LLC | $233.21 | 2021-2025 | Mentor Cpx 4 Breast Tissue Expander |
| Galderma Laboratories, L.P. | $101.33 | 2022 | |
| Bard Peripheral Vascular, INC. | $85.72 | 2021 | |
| Tela Bio, INC. | $70.73 | 2024 | Ovitex 2s |
| Integra Lifesciences Corporation | $64.44 | 2024 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Polynovo North America LLC | $41.53 | 2022-2024 | Novosorb Btm |
| Sientra, INC. | $34.26 | 2021 | |
| Davol INC. | $20.46 | 2021 | |
| Kci USA, INC. | $15.46 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $10.15 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Farber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.